CDC loosens mask guidelines as omicron surge subsides
Feb 25, 2022
Under new recommendations, >70% of Americans now live in areas where masking in public indoor settings is no longer advised.
CDC close to new guidance on COVID-19 restrictions
Feb 24, 2022
The agency wants to give more emphasis to meaningful consequences, such as hospitalizations, emergency room visits and deaths.
Baricitinib reduces mortality in critically ill adults with COVID-19
Feb 18, 2022
A reduction in death was seen at 28 and 60 days for patients receiving invasive mechanical ventilation and extracorporeal membrane oxygenation.
Long-term care financing success requires federal program, coverage across continuum: report
By
Kimberly Bonvissuto
Feb 08, 2022
A new federal benefit that would include taxpayer subsidies and cover the continuum of long-term care services, including residential care and home- and community-based services, would address some of...
50 National Guard members activated to help Utah LTC facilities, hospitals ease staffing shortages
By
Kathleen Steele Gaivin
Feb 03, 2022
The Utah National Guard’s COVID-19 Joint Task Force has activated approximately 50 service members statewide, according to Tuesday’s official statement from the National Guard. The move is meant to...
Remdesivir offers some benefit for hospitalized COVID-19 patients
Feb 01, 2022
No difference was seen for in-hospital mortality, but a need for initiation of mechanical ventilation was reduced with the addition of remdesivir to standard care.
Canceling OSHA healthcare standard puts workers in ‘grave danger,’ unions tell court
By
Kathleen Steele Gaivin
Feb 01, 2022
The federal government has placed healthcare workers in “grave danger” by withdrawing portions of the Occupational Health and Safety Administration’s COVID-19 healthcare emergency temporary standard,...
‘Stealth’ version of omicron variant no cause for alarm, experts say
Jan 31, 2022
The new version of the variant does not appear to cause more severe disease, and vaccines are effective against it.
Neutralization titers against omicron up with mRNA-1273 boost
Jan 28, 2022
After a mRNA-1273 (Moderna) boost, neutralization titers against the omicron variant were 20 times higher than than those at one month after second dose.
Thrombosis, thrombocytopenia syndrome up after Ad26.COV2.S
Jan 28, 2022
Rates of 3.83 per million vaccine doses for Ad26.COV2.S (Johnson & Johnson) have been reported, versus 0.00855 per million for mRNA-based vaccines such as Pfizer-BioNTech and Moderna.